Jennifer Leigh Nelson

This inventor holds 26 USPTO granted patents and 10 published patent applications, plus 3 CIPO patents and 4 EPO patents, primarily in Pharmaceutical Crystallization. Top assignees: Dermira, Inc., Basf Se Corporation, Bristol-Myers Squibb Compnay. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer Leigh Nelson. Retrieved from https://idiyas.com/inventor/jennifer-leigh-nelson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 26 (Patent Applications = 10)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 6.4

ph-index = 6

Forward Citations = 113(Granted Patents)

Company Filing History:

Bristol-Myers Squibb Compnay

Journey Medical Corporation

patents

6. 2 out of 44

Mirati Therapeutics, Inc.

patents

7. 1 out of 42

Jazz Pharmaceuticals Ireland Limited

Sk Biopharmaceuticals Co., Ltd.

patents

11. 1 out of 15

Sumitomo Pharma Co., Ltd.

patents

12. 1 out of 834,659

Other

patents

where one patent can have more than one assignee

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

IDO Inhibitors

KRas G12C Inhibitor

Glycopyrrolate Salts

Purification Methods

Cocrystals

Solid State Forms

Amorphous Forms

Crystalline Forms

Pharmaceuticals

Carbamates

PDE10 Inhibitor

L-glufosinate

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12767654 - 2-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-indol-5-yl)piperidin-1-yl)acetamide salt and crystalline forms thereof (2026-10-20),

2. 12758895 - Methods for the purification of L-glufosinate (2026-10-13),

3. 12735430 - Crystalline solvated forms of N-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea (2026-09-15),

4. 12421195 - Amorphous and crystalline forms of IDO inhibitors (2025-09-23),

5. 12286431 - Crystalline forms of a KRas G12C inhibitor (2025-04-29),

6. 12281113 - Crystalline forms of a KRas G12C inhibitor (2025-04-21),

7. 11976089 - Methods for the purification of L-glufosinate (2024-05-07),

8. 11897909 - Methods for the purification of L-glufosinate (2024-02-13),

9. 11897908 - Methods for the purification of L-glufosinate (2024-02-13),

10. 11634442 - Methods for the purification of L-glufosinate (2023-04-25),

11. 11291652 - Glycopyrrolate salts (2022-04-05),

12. 11291651 - Glycopyrrolate salts (2022-04-05),

13. 11236049 - Amorphous and crystalline forms of IDO inhibitors (2022-02-01),

14. 10829443 - Solvate form of (R)-2-amino-3-phenylpropyl carbamate (2020-11-10),

15. 10548875 - Glycopyrrolate salts (2020-02-04),

Title: Jennifer Leigh Nelson: Innovator in L-Glufosinate Purification

Introduction: Jennifer Leigh Nelson, based in Kokomo, Indiana, is a prominent inventor with a remarkable portfolio of 20 patents. Her work primarily focuses on the purification of L-glufosinate, showcasing her expertise in the development of solid forms of this material.

Latest Patents: Among her notable patents, Jennifer has contributed to the field with two significant inventions: "Methods for the purification of L-glufosinate - Solid forms of L-glufosinate materials, including crystalline L-glufosinate ammonium." These patents emphasize advancements in the purification processes and solid forms of L-glufosinate, which is essential for various applications.

Career Highlights: Throughout her career, Jennifer has worked with reputable companies such as Dermira, Inc. and BASF SE Corporation. Her contributions in these organizations have greatly impacted their research and development efforts, particularly in the agricultural and chemical sciences.

Collaborations: Jennifer has had the opportunity to work alongside notable colleagues, including Patricia Andres and John Allan Statler. Collaborating with such talented individuals has enriched her research endeavors and fostered a productive working environment.

Conclusion: Jennifer Leigh Nelson's innovative contributions to the purification of L-glufosinate place her at the forefront of her field. With a solid patent portfolio and collaborations with industry leaders, she continues to make significant strides in the realm of chemical innovation, positioning herself as a key figure in this specialized area.

Profile summary based on public USPTO records.